Bright Minds Biosciences expands Scientific Advisory Board
Bright Minds Biosciences (DRUG) announced the expansion of its Scientific Advisory Board to include five distinguished experts in epilepsy ...
Yahoo Finance18d
Bright Minds Biosciences to Participate at Three Healthcare Conferences in March
The replay of the webcast will be accessible for 90 days. Bright Minds Biosciences is a biotechnology company developing innovative treatments for patients with neurological and psychiatric disorders.
Business Insider28d
Bright Minds Biosciences (DRUG) Receives a New Rating from Piper Sandler
Piper Sandler analyst Yasmeen Rahimi initiated coverage with a Buy rating on Bright Minds Biosciences (DRUG – Research Report) today and set a price target of $93.00. The company’s shares ...
Yahoo Finance10d
Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research
“We are fortunate to welcome these accomplished and highly respected researchers to the Bright Minds team at this exciting juncture. As we advance our clinical programs through the regulatory ...
manilatimes18d
Bright Minds Biosciences to Participate at Three Healthcare Conferences in March
The replay of the webcast will be accessible for 90 days. Bright Minds Biosciences is a biotechnology company developing innovative treatments for patients with neurological and psychiatric disorders.